Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A sequence-randomized, open-label, single dose, crossover study to evaluate pharmacokinetics and safety after oral administration of Plavix (75mg) and Astrix (100mg) in free combination and fixed-dose combination as HCP0911 in healthy male volunteers.

Next Previous
X
Search
Trial Profile

A sequence-randomized, open-label, single dose, crossover study to evaluate pharmacokinetics and safety after oral administration of Plavix (75mg) and Astrix (100mg) in free combination and fixed-dose combination as HCP0911 in healthy male volunteers.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Aspirin/clopidogrel (Primary) ; Aspirin; Clopidogrel
  • Indications Cardiovascular disorders; Thrombosis
  • Focus Pharmacokinetics
  • Acronyms HM-CPAS-101
  • Sponsors Hanmi Pharmaceutical

    • Most Recent Events

    • 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
    • 23 Nov 2011 Official Title amended as reported by Clinical Research Information Service (CriS) - Republic of Korea record.
    • 23 Nov 2011 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000256).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top